Management of impulse control disorders in Parkinson's disease: Controversies and future approaches-Reference-Cited by-同舟云学术

Management of impulse control disorders in Parkinson's disease: Controversies and future approaches

Published:2015-01-21 Issue:2 Volume:30 Page:150-159
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord.

Author:

Samuel Michael¹,Rodriguez-Oroz Maria²,Antonini Angelo³,Brotchie Jonathan M.⁴,Ray Chaudhuri Kallol¹⁵,Brown Richard G.⁶,Galpern Wendy R.⁷,Nirenberg Melissa J.⁸,Okun Michael S.⁹,Lang Anthony E.¹⁰

Affiliation:

1. Department of Neurology; National Parkinson Foundation International Centre of Excellence, King's College Hospital, King's Health Partners; London UK

2. Department of Neurology; University Hospital Donostia; Neuroscience Unit BioDonostia Research Institute, San Sebastian; Ikerbasque, Basque Foundation for Science, Bilbao; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED); Spain

3. Fondazione Ospedale San Camillo- I.R.C.C.S., Parkinson Unit; Venice Italy

4. Toronto Western Research Institute, Toronto Western Hospital; 60 Leonard St, KDT 8-402 Toronto Ontario M5T 2S8 Canada

5. Department of Clinical Neuroscience; Institute of Psychiatry, King's College London; UK

6. King's College London, Institute of Psychiatry; Department of Psychology (PO77) De Crespigny Park; London SE5 8AF UK

7. National Institute of Neurological Disorders and Stroke; National Institutes of Health; Bethesda MD USA

8. Department of Neurology; NYU School of Medicine; New York NY USA

9. UF Center for Movement Disorders and Neurorestoration; 3450 Hull Road, 4th Floor Gainesville FL 32607 USA

10. Morton and Gloria Movement Disorders Clinic and the Edmond J. Safra Program in Parkinson's Disease, Toronto Western Hospital; Toronto ON Canada

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Reference95 articles.

1. Linking neuroscience with modern concepts of impulse control disorders in Parkinson's disease;Napier;Mov Disord,2014

2. Parkinson's disease, the subthalamic nucleus, inhibition and impulsivity;Jahanshahi;Mov Disord,2014

3. Clinical spectrum of impulse control disorders in Parkinson's disease;Weintraub;Mov Disord,2014

4. Impulsive and compulsive behaviors in Parkinson's disease;Evans;Mov Disord,2009

5. Orally disintegrating selegiline in Parkinson patients with dopamine agonist-related adverse effects;Lyons;Clin Neuropharmacol,2010

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The efficacy and safety of gene therapy approaches in Parkinson's disease: A systematic review;Disease-a-Month;2024-07

2. New Perspectives of Deep Brain Stimulation Indications for Parkinson’s Disease: A Critical Review;Brain Sciences;2024-06-26

3. How to Use the New European Academy of Neurology/Movement Disorder Society European Section Guideline for Invasive Therapies in Parkinson's Disease;Movement Disorders Clinical Practice;2024-01-12

4. Predictors of Burden in Carers of Patients with Impulse Control Behaviors in Parkinson's Disease;Movement Disorders Clinical Practice;2023-07-26

5. Efficacy and safety of clonidine for the treatment of impulse control disorder in Parkinson’s disease: a multicenter, parallel, randomised, double-blind, Phase 2b Clinical trial;Journal of Neurology;2023-06-20